Continuous manufacturing may offer huge opportunities, but it will not be right for every facility or product. On May 6, 2019, at St. John’s University in New York City, the 11th annual Charles ...

Going from batch to continuous processing may not seem like a major issue, but that’s not the case in the pharmaceutical and biotechnology industry. Continuous processing works fine in most ...

To strive for continuous flow or not? While certain processes achieve immediate gains from the pursuit of continuous flow, many experience the burdens of the pursuit outweighing the gains, if there ...

At the just completed BioProcess International Conference in Boston, a number of sessions focused on the Bioprocess 4.0 trend toward continuous bioprocessing operations. Akshat Mullerpatan, PhD, ...

Continuous manufacturing is the way of the future for solid-dosage pharmaceuticals, but one of the challenges for implementation is how to define a batch for quality assurance testing. Continuous ...

Continuous processing can get products to market about 12 months faster than batch processing, according to a 2022 paper by the FDA. Understandably, the drive to transition to continuous bioprocessing ...

At a recent meeting in Boston, representatives from global pharmaceutical companies gathered to discuss how to transition from batch to continuous manufacturing. And what company better to learn from ...